These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 7891077)
21. Increased expression of gelatinases and collagenase in rat lungs exposed to 100% oxygen. Pardo A; Selman M; Ridge K; Barrios R; Sznajder JI Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):1067-75. PubMed ID: 8887609 [TBL] [Abstract][Full Text] [Related]
22. An inverse correlation between expression of NCAM-A and the matrix-metalloproteinases gelatinase-A and gelatinase-B in human glioma cells in vitro. Maidment SL; Rucklidge GJ; Rooprai HK; Pilkington GJ Cancer Lett; 1997 Jun; 116(1):71-7. PubMed ID: 9177460 [TBL] [Abstract][Full Text] [Related]
23. Increased matrix metalloproteinases in the aqueous humor of patients and experimental animals with uveitis. Di Girolamo N; Verma MJ; McCluskey PJ; Lloyd A; Wakefield D Curr Eye Res; 1996 Oct; 15(10):1060-8. PubMed ID: 8921246 [TBL] [Abstract][Full Text] [Related]
24. Beta-amyloid induces the production of active, matrix-degrading proteases in cultured rat astrocytes. Deb S; Wenjun Zhang J; Gottschall PE Brain Res; 2003 Apr; 970(1-2):205-13. PubMed ID: 12706262 [TBL] [Abstract][Full Text] [Related]
25. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276 [TBL] [Abstract][Full Text] [Related]
26. Characterization of extracellular matrix-degrading proteinase and its inhibitor in gynecologic cancer tissues with clinically different metastatic form. Tamakoshi K; Kikkawa F; Nawa A; Ishikawa H; Mizuno K; Tamakoshi A; Yamagata S; Suganuma N; Tomoda Y Cancer; 1995 Dec; 76(12):2565-71. PubMed ID: 8625086 [TBL] [Abstract][Full Text] [Related]
27. Production of gelatin-degrading matrix metalloproteinases ('type IV collagenases') and inhibitors by articular chondrocytes during their dedifferentiation by serial subcultures and under stimulation by interleukin-1 and tumor necrosis factor alpha. Lefebvre V; Peeters-Joris C; Vaes G Biochim Biophys Acta; 1991 Aug; 1094(1):8-18. PubMed ID: 1653026 [TBL] [Abstract][Full Text] [Related]
28. Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia. Clark AW; Krekoski CA; Bou SS; Chapman KR; Edwards DR Neurosci Lett; 1997 Nov; 238(1-2):53-6. PubMed ID: 9464653 [TBL] [Abstract][Full Text] [Related]
29. Inter-regulated balance between gelatinases and tissue inhibitor (TIMP-1) in isolated human glomeruli. Zaoui P; Barro C; Maynard C; Descotes JL; Maurizi-Balzan J; Cordonnier DJ; Morel F Ren Fail; 1998 Mar; 20(2):201-9. PubMed ID: 9574444 [TBL] [Abstract][Full Text] [Related]
30. Matrix metalloproteinase production by cultured human endometrial stromal cells: identification of interstitial collagenase, gelatinase-A, gelatinase-B, and stromelysin-1 and their differential regulation by interleukin-1 alpha and tumor necrosis factor-alpha. Rawdanowicz TJ; Hampton AL; Nagase H; Woolley DE; Salamonsen LA J Clin Endocrinol Metab; 1994 Aug; 79(2):530-6. PubMed ID: 8045973 [TBL] [Abstract][Full Text] [Related]
31. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis. Kossakowska AE; Edwards DR; Lee SS; Urbanski LS; Stabbler AL; Zhang CL; Phillips BW; Zhang Y; Urbanski SJ Am J Pathol; 1998 Dec; 153(6):1895-902. PubMed ID: 9846979 [TBL] [Abstract][Full Text] [Related]
32. Production of both 92- and 72-kDa gelatinases by bone cells. Lorenzo JA; Pilbeam CC; Kalinowski JF; Hibbs MS Matrix; 1992 Aug; 12(4):282-90. PubMed ID: 1435512 [TBL] [Abstract][Full Text] [Related]
33. In vitro expression of MMP-2 and MMP-9 in glioma cells following exposure to inflammatory mediators. Esteve PO; Tremblay P; Houde M; St-Pierre Y; Mandeville R Biochim Biophys Acta; 1998 May; 1403(1):85-96. PubMed ID: 9622599 [TBL] [Abstract][Full Text] [Related]
34. Expression of matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) induced by tumour necrosis factor alpha correlates with metastatic ability in a human osteosarcoma cell line. Kawashima A; Nakanishi I; Tsuchiya H; Roessner A; Obata K; Okada Y Virchows Arch; 1994; 424(5):547-52. PubMed ID: 8032535 [TBL] [Abstract][Full Text] [Related]
36. Expression of multiple matrix metalloproteinases and urokinase type plasminogen activator in cultured Kaposi sarcoma cells. Meade-Tollin LC; Way D; Witte MH Acta Histochem; 1999 Jul; 101(3):305-16. PubMed ID: 10443293 [TBL] [Abstract][Full Text] [Related]
37. Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A. Okada A; Tomasetto C; Lutz Y; Bellocq JP; Rio MC; Basset P J Cell Biol; 1997 Apr; 137(1):67-77. PubMed ID: 9105037 [TBL] [Abstract][Full Text] [Related]
38. The effect of exogenous gangliosides on matrix metalloproteinase secretion by human glioma cells in vitro. Maidment SL; Merzak A; Koochekpour S; Rooprai HK; Rucklidge GJ; Pilkington GJ Eur J Cancer; 1996 May; 32A(5):868-71. PubMed ID: 9081368 [TBL] [Abstract][Full Text] [Related]
39. Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate. Lohi J; Lehti K; Westermarck J; Kähäri VM; Keski-Oja J Eur J Biochem; 1996 Jul; 239(2):239-47. PubMed ID: 8706726 [TBL] [Abstract][Full Text] [Related]
40. Cleavage and activation of corneal matrix metalloproteases by Pseudomonas aeruginosa proteases. Matsumoto K; Shams NB; Hanninen LA; Kenyon KR Invest Ophthalmol Vis Sci; 1993 May; 34(6):1945-53. PubMed ID: 8491548 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]